Author： Lox C. Ronaghan C. Cobos E.
Publisher： Elsevier
ISSN： 0306-3623
Source： General Pharmacology, Vol.30, Iss.1, 1998-01, pp. : 121-124
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Tamoxifen a worthwhile investment for women at risk for breast cancer
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 252, 2000-01 ,pp. :
Access to resources
Recommend
Tamoxifen a worthwhile investment for women at risk for breast cancer
Inpharma, Vol. 1, Iss. 1227, 2000-01 ,pp. :
Breast cancer drug for women who fail to respond to tamoxifen
By Bradley D.
Pharmaceutical Science & Technology Today, Vol. 3, Iss. 11, 2000-11 ,pp. :
Tamoxifen link to breast cancer confirmed
Reactions Weekly, Vol. 1, Iss. 1269, 2009-01 ,pp. :
PharmacoEconomics, Vol. 20, Iss. 2, 2002-02 ,pp. :